What Benlysta treats
Benlysta (belimumab) is a biologic medication specifically designed to treat systemic lupus erythematosus (SLE) and lupus nephritis. By targeting and inhibiting a specific protein involved in the immune response, Benlysta helps reduce inflammation and disease activity.
How Does Benlysta Work?
Benlysta works by targeting and inhibiting the activity of the B-lymphocyte stimulator (BLyS) protein. This protein promotes the survival and growth of B cells, which are a type of white blood cell involved in the immune response. In lupus, these B cells become overactive and attack the body’s own tissues. By inhibiting BLyS, Benlysta reduces the number of abnormal B cells, helping to decrease inflammation and prevent disease flare-ups. Benlysta is administered through intravenous infusion or subcutaneous injection, with dosing tailored to the patient’s specific condition.
Benefits of Benlysta
The treatment goals in the conditions Benlysta is approved to treat include reduced disease flare-ups, decreased fatigue, and better management of lupus-related symptoms. Whether an individual patient reaches them varies, and is assessed by the prescribing clinician. By targeting the underlying cause of inflammation, Benlysta helps improve overall quality of life and reduce the need for corticosteroids, which can have significant side effects when used long-term.
Possible Side Effects of Benlysta
Some patients experience side effects, including nausea, diarrhea, fever, and headaches. Injection site reactions, such as redness or swelling, may occur with the subcutaneous form. Serious side effects can include an increased risk of infections, allergic reactions, and mood changes, including depression. It’s important to stay in close contact with your healthcare provider and report any unusual symptoms.
How infusion works at Prime
Benlysta is administered at our infusion centers across New York and Atlanta. Our dedicated care team coordinates every step of your treatment with your prescribing physician.
Getting started
Patients: if you have a referral for Benlysta, send us an inquiry using the form below and our care team will take it from there. Physicians: referring a patient to Prime Infusions is simple — just complete and fax or email the referral form above.
Ready to start?
For a medical emergency, call 911.
Our Infusion Centers
FAQ
Frequently asked questions
Who is Benlysta For?
Benlysta is suitable for adults and children (5 years and older) with active, autoantibody-positive systemic lupus erythematosus (SLE) or lupus nephritis who have not responded adequately to standard therapies. It is often recommended when previous treatments have been ineffective or insufficient in controlling disease activity.